S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
The single greatest medical breakthrough of all time? (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
The single greatest medical breakthrough of all time? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
The single greatest medical breakthrough of all time? (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
The single greatest medical breakthrough of all time? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
The single greatest medical breakthrough of all time? (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
The single greatest medical breakthrough of all time? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
The single greatest medical breakthrough of all time? (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
The single greatest medical breakthrough of all time? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
NYSE:TFX

Teleflex (TFX) Stock Forecast, Price & News

$237.04
-1.52 (-0.64%)
(As of 06/9/2023 ET)
Compare
Today's Range
$236.20
$239.56
50-Day Range
$232.06
$274.11
52-Week Range
$182.65
$276.43
Volume
197,583 shs
Average Volume
228,656 shs
Market Capitalization
$11.12 billion
P/E Ratio
30.90
Dividend Yield
0.57%
Price Target
$273.38

Teleflex MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
15.3% Upside
$273.38 Price Target
Short Interest
Bearish
3.58% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
0.28mentions of Teleflex in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$742,290 Sold Last Quarter
Proj. Earnings Growth
9.41%
From $13.29 to $14.54 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.31 out of 5 stars

Medical Sector

228th out of 987 stocks

Surgical & Medical Instruments Industry

19th out of 94 stocks


TFX stock logo

About Teleflex (NYSE:TFX) Stock

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Stock News Headlines

[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Teleflex: FDA Clears Arrow EZ-IO Needle As MR Conditional
Teleflex (NYSE:TFX) Coverage Initiated at CL King
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Expert Ratings for Teleflex
StockNews.com Begins Coverage on Teleflex (NYSE:TFX)
Teleflex Publishes 2022 Global Impact Report
Teleflex (NYSE:TFX) Upgraded at StockNews.com
See More Headlines

TFX Price History

TFX Company Calendar

Ex-Dividend for 3/15 Dividend
3/02/2023
Dividend Payable
3/15/2023
Last Earnings
5/04/2023
Ex-Dividend for 6/15 Dividend
5/12/2023
Today
6/09/2023
Dividend Payable
6/15/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
87936910
Employees
15,500
Year Founded
1943

Price Target and Rating

Average Stock Price Forecast
$273.38
High Stock Price Forecast
$330.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+15.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
12 Analysts

Profitability

Net Income
$363.14 million
Pretax Margin
15.73%

Debt

Sales & Book Value

Annual Sales
$2.79 billion
Cash Flow
$17.94 per share
Book Value
$85.74 per share

Miscellaneous

Free Float
46,239,000
Market Cap
$11.12 billion
Optionable
Optionable
Beta
1.00

Social Links


Key Executives

  • Mr. Liam J. KellyMr. Liam J. Kelly (Age 56)
    Chairman, Pres & CEO
    Comp: $2M
  • Mr. Thomas E. Powell (Age 61)
    Exec. VP & CFO
    Comp: $1.04M
  • Mr. Cameron P. HicksMr. Cameron P. Hicks (Age 58)
    Corp. VP of HR & Communications
    Comp: $564.68k
  • Mr. Jay White (Age 49)
    Corp. VP & Pres of Global Commercial
    Comp: $866.86k
  • Mr. John R. Deren
    Corp. VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy
    VP & Chief Information Officer
  • Mr. John Hsu C.F.A.
    VP of Investor Relations
  • Mr. Daniel V. Logue (Age 49)
    Corp. VP, Gen. Counsel & Sec.
  • Mr. Howard Cyr
    Corp. VP & Chief Compliance Officer
  • Mr. Matt Tomkin
    VP of Corp. Devel.













TFX Stock - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TFX shares.
View TFX analyst ratings
or view top-rated stocks.

What is Teleflex's stock price forecast for 2023?

12 brokers have issued 12 month price targets for Teleflex's stock. Their TFX share price forecasts range from $210.00 to $330.00. On average, they anticipate the company's share price to reach $273.38 in the next year. This suggests a possible upside of 15.3% from the stock's current price.
View analysts price targets for TFX
or view top-rated stocks among Wall Street analysts.

How have TFX shares performed in 2023?

Teleflex's stock was trading at $249.63 at the beginning of 2023. Since then, TFX shares have decreased by 5.0% and is now trading at $237.04.
View the best growth stocks for 2023 here
.

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our TFX earnings forecast
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) released its quarterly earnings data on Thursday, May, 4th. The medical technology company reported $3.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.97 by $0.12. The medical technology company earned $710.90 million during the quarter, compared to analysts' expectations of $687.11 million. Teleflex had a net margin of 12.68% and a trailing twelve-month return on equity of 15.80%. The company's revenue for the quarter was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.88 earnings per share.
Read the conference call transcript
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Monday, May 8th. Investors of record on Monday, May 15th will be given a dividend of $0.34 per share on Thursday, June 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Friday, May 12th.
Read our dividend analysis for TFX
.

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.57%. The dividend payout ratio is 17.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.35% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided EPS guidance of $13.00-$13.60 for the period, compared to the consensus earnings per share estimate of $13.29. The company issued revenue guidance of $2.92 billion-$2.96 billion, compared to the consensus revenue estimate of $2.93 billion.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.48%), Wellington Management Group LLP (6.60%), State Street Corp (4.96%), Price T Rowe Associates Inc. MD (3.90%), Geode Capital Management LLC (2.07%) and Allspring Global Investments Holdings LLC (1.80%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends
.

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $237.04.

How much money does Teleflex make?

Teleflex (NYSE:TFX) has a market capitalization of $11.12 billion and generates $2.79 billion in revenue each year. The medical technology company earns $363.14 million in net income (profit) each year or $7.67 on an earnings per share basis.

How many employees does Teleflex have?

The company employs 15,500 workers across the globe.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.

This page (NYSE:TFX) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -